Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine coronavirus.
CANINE CORONAVIRUS VACCINE
Nobivac® Canine 1-Cv is a killed virus vaccine shown to be effective against canine coronavirus.
- The virus has been inactivated and combined with an adjuvant designed to enhance the immune response
- Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine coronavirus.
Recommended for use in healthy dogs 6 weeks of age or older.
ADMINISTRATION AND DOSAGE
- Inject initial 1 mL dose subcutaneously or intramuscularly
- The initial dose may be given at 6 weeks of age
- A second, required dose is given 2-4 weeks later
- Contact your veterinarian or manufacturer for more information on revaccination frequency.
- Use entire contents immediately
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Quick Guide to Lepto
A handy guide to protect dogs and prevent the spread of leptospirosis.
Nobivac® Social Media Kits
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
AAHA Canine Vaccination Guidelines
In-depth information about canine vaccinations and veterinary best practices.
No items to show.